Find or Sell Used Cars, Trucks, and SUVs in USA

1999 Porsche Boxster on 2040-cars

US $12,545.00
Year:1999 Mileage:52108 Color: Silver /
 Black
Location:

Advertising:
Vehicle Title:Clean
Engine:2.5L H6 DOHC 24V
Fuel Type:Gasoline
Body Type:Convertible
Transmission:Automatic
For Sale By:Dealer
Year: 1999
VIN (Vehicle Identification Number): WP0CA2985XU628525
Mileage: 52108
Make: Porsche
Features: --
Power Options: --
Exterior Color: Silver
Interior Color: Black
Warranty: Unspecified
Model: Boxster
Condition: Used: A vehicle is considered used if it has been registered and issued a title. Used vehicles have had at least one previous owner. The condition of the exterior, interior and engine can vary depending on the vehicle's history. See the seller's listing for full details and description of any imperfections. See all condition definitions

Auto blog

Ferrari return to Le Mans looking more likely?

Wed, 18 Dec 2013

Statements made by Ferrari president Luca di Montezemolo may indicate that the Italian brand could return to a form of racing it's been absent from for 40 years - prototype racing. That's right, LMP1 could see a factory Ferrari team for the first time since 1973, if a report from ESPN F1 is to be believed.
"We have won with the 458 GTE, but I also quite like the idea of racing at Le Mans in the highest category: who knows, maybe one day we can return and win, say thanks and come home," Montezemolo said. "Maybe we should give it some consideration..."
These seemingly idle, off-hand comments might not hold much water, were rumors about Ferrari's return to prototype racing not swirling as recently as August. There's also the fact that the upcoming, 1.6-liter, turbocharged V6 being used for Formula One complies with the Automobile Club de l'Ouest's own LMP1 regulations, according to ESPN. Finally, Ferrari returning to Le Mans might also explain this video of a camouflaged Ferrari LaFerrari testing a new turbocharged engine, which we showed you a few weeks back. There's a fair chance that what we're actually seeing in that video are the early stages of a new Ferrari prototype testing.

Porsche 918 Spyder to birth stretched 2+2 version?

Fri, 23 Aug 2013

Porsche is known for its ability to spin off a litter of variants from a single model, and according to a report in Automobile the 918 Spyder (pictured here) might not be spared the house trick. Having taken too many brains and too much money for too much time, company chiefs are said to be examining ways to get more for their development euro out of the supercar, and Plan A is apparently otherwise known as Plan 984. That would be a four-seater, rear-wheel drive supercar that uses a stretched mold of the 918's carbon fiber tub, keeping the V8 in the same mid-mounted place and costing around 350,000 euro.
That would be less than half the MSRP of its inspiration, but the details don't sketch out a car that's just half as good. Automobile speculates it would get something like 700 horsepower in order to best the coming 911 GT2, and about 440 pound-feet of torque. The 984 is quite a ways short of being confirmed; even though a full-size study is said to exist, it's like the 918 would need to become a bigger sales hit for the 984 to happen.
The 984's fortunes don't change those of the 960, the supercoupe Porsche is building to challenge Ferrari. Its potential specs haven't changed since the last report in January, power coming from a 5.0-liter, twin-turbo, eight-cylinder boxer engine with something like 650 hp pushing a curb weight of roughly 3,100 pounds. The means a suspected 0-to-60 mile-per-hour time of 2.5 seconds.

Porsche suspends ties with Maria Sharapova after drug test

Tue, Mar 8 2016

Porsche has reportedly suspended ties with Maria Sharapova after the Russian tennis star failed a drug test. The German automaker stopped short of terminating its relationship with the athlete altogether as it awaits the results of a deeper investigation. The issue emerged at the Australian Open, where Sharapova reportedly tested positive for use of a drug called meldonium. Manufactured in Latvia and prescribed in many former Soviet Bloc countries, meldonium is used to treat heart conditions and improve cardiac circulation. It is not approved by the FDA for use in the United States, and the World Anti-Doping Agency added it to its list of prohibited substances at the start of this year. Sharapova admitted that she's been taking the medication for ten years now but that she did not keep up to date on the WADA's list. Since it is considered a prohibited substance, she's been excluded from participating in the Australian Open this year, and suspended from competition as of March 12. She was also scheduled to take part in the Porsche Grand Prix, a tennis event sponsored by the carmaker in Stuttgart next month which she will now apparently have to miss. One of the top-rated female tennis players in the world, Sharapova has served as a brand ambassador for Porsche since 2013. Other sponsors including TAG Heuer and Nike have also reportedly suspended their relationships with the athlete pending further investigation by the International Tennis Federation. Related Video: